A10 is a central piece in the core of the poxvirus. A new study from researchers at the Institute of Science and Technology Austria (ISTA) (Klosterneuburg, Austria), has finally shed light on this ...
Imugene Ltd has secured a patent in India for its exclusively licensed CF33 oncolytic virotherapy technology. Issued under patent number 558994, the patent provides 20 years of protection from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback